Christopher Gibson - Apr 5, 2023 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Signature
/s/ Jonathan Golightly, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Apr 5, 2023
Transactions value $
-$274,210
Form type
4
Date filed
4/7/2023, 05:30 PM
Previous filing
Mar 15, 2023
Next filing
May 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Gift $0 -10K -1.07% $0.00 929K Apr 5, 2023 Direct F1
transaction RXRX Class A Common Stock Options Exercise $77.5K +31.3K +3.36% $2.48 960K Apr 5, 2023 Direct F1
transaction RXRX Class A Common Stock Sale -$86K -13.3K -1.39% $6.46 947K Apr 5, 2023 Direct F1, F2
transaction RXRX Class A Common Stock Sale -$266K -40K -4.23% $6.64 907K Apr 6, 2023 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Stock Option (Right to Buy) Options Exercise $0 -31.3K -4.55% $0.00 656K Apr 5, 2023 Class A Common Stock 31.3K $2.48 Direct F1, F6
holding RXRX Stock Option (Right to Buy) 814K Apr 5, 2023 Class A Common Stock 0 $8.55 Direct F4
holding RXRX Stock Option (Right to Buy) 5.44K Apr 5, 2023 Class A Common Stock 0 $11.40 Direct
holding RXRX Stock Option (Right to Buy) 416K Apr 5, 2023 Class A Common Stock 0 $11.40 Direct F5
holding RXRX Class B Common Stock 6.62M Apr 5, 2023 Class A Common Stock 0 $0.00 Direct F7
holding RXRX Class B Common Stock 535K Apr 5, 2023 Class A Common Stock 0 $0.00 by LAHWRAN-3 LLC F7, F8
holding RXRX Class B Common Stock 508K Apr 5, 2023 Class A Common Stock 0 $0.00 by LAHWRAN-4 LLC F7, F9
holding RXRX Class B Common Stock 124K Apr 5, 2023 Class A Common Stock 0 $0.00 by Gibson Family Trust F7, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting person on December 22, 2022.
F2 This transaction was executed in multiple trades at prices ranging from $6.451 to $6.495. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 This transaction was executed in multiple trades at prices ranging from $6.365 to $6.725. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F5 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F6 The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F7 Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F8 The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
F9 The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
F10 The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.